What is the purpose of using aminocaproic acid in bleeding disorders?

• A. It is an antifibrinolytic agent used to prevent clots from breaking down.
• B. It increases platelet production in the bone marrow.
• C. It directly stimulates fibrin formation.
• D. It reduces platelet aggregation.

Answer: (A)

The main idea is that stopping excessive breakdown of clots helps control bleeding. Aminocaproic acid acts as an antifibrinolytic, meaning it prevents the enzymes that dissolve clots from working. It inhibits the activation of plasminogen to plasmin and reduces plasmin activity, so formed fibrin clots are preserved and less likely to be broken down. This makes it useful in bleeding disorders or situations where fibrinolysis is too active.

It does not increase platelet production in the bone marrow, it does not directly stimulate the formation of fibrin, and it does not reduce platelet aggregation. Those effects would come from other therapies: agents that stimulate platelet production, factors that drive the coagulation cascade to form fibrin, or antiplatelet drugs that lessen platelet clumping.